Cognitive Impairment Imaging Techniques in Aging

Ageing is accompanied by structural and functional brain changes that underlie cognitive decline. Structural imaging techniques such as volumetric MRI and diffusion tensor imaging enable precise measurement of grey matter atrophy and white matter microstructure. Functional methods—including task-based and resting-state fMRI—reveal disruptions in memory, attention and executive networks. Molecular imaging with positron emission tomography allows in vivo mapping of amyloid and tau pathology, while arterial spin labelling quantifies cerebral perfusion without contrast agents. Recent advances integrate ultra-high-field MRI, novel PET tracers and machine learning to enhance early detection, prognostic stratification and monitoring of therapeutic interventions. Harmonisation of acquisition protocols and multicentre collaborations are driving efforts to translate these biomarkers into clinical practice. Collectively, these multimodal approaches provide a window into the progression from healthy ageing to mild cognitive impairment and dementia, informing both personalised treatment strategies and public health initiatives.

Research from Nature Portfolio

A seminal functional MRI study demonstrated that carriers of the APOE ε4 allele exhibit altered engagement of the posteromedial cortex during scene perception and short-term memory tasks. This selective inability to modulate a key hub within the default mode network overlaps topographically with regions vulnerable in Alzheimer’s disease, indicating that such early-life functional perturbations may presage later cognitive decline.

Cognitive Impairment Imaging Techniques in Aging publication trend

The graph below shows the total number of articles in cognitive impairment imaging techniques in aging across all publications each year (not limited to Nature Index journals).

Technical terms

Functional MRI (fMRI): non-invasive technique that detects changes in blood oxygenation to infer neural activity during tasks or rest.

Diffusion Tensor Imaging (DTI): MRI method mapping white matter microstructure by measuring the directional diffusion of water molecules along axonal tracts.

Arterial Spin Labelling (ASL): perfusion MRI approach that labels arterial blood water as an endogenous tracer to measure cerebral blood flow quantitatively.

Positron Emission Tomography (PET): nuclear imaging technique using radiotracers to visualise molecular processes such as amyloid or tau aggregation.

Functional Connectivity: statistical association of activity patterns between distinct brain regions, assessed during rest or cognitive tasks.

Hyperactivation: increased neural response observed in functional imaging paradigms, which may indicate compensatory mechanisms or incipient pathology.

References

1. Cerebral hyperactivation across the Alzheimer’s disease pathological cascade. Brain Communications (2024).
2. Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment. Journal of Neurology (2018).
3. Latent patterns of task-related functional connectivity in relation to regions of hyperactivation in individuals at risk of Alzheimer’s disease. NeuroImage Clinical (2021).
4. Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features. International Journal of Molecular Sciences (2022).
5. APOE-ε4 selectively modulates posteromedial cortex activity during scene perception and short-term memory in young healthy adults. Scientific Reports (2015).